Global Antibiotic Research and Development Partnership
room 15 Chemin Camille-Vidart | 1202 Geneva | Switzerland
arrow_back See all Activities

Children's Antibiotics

IATI Identifier:

Published on IATI
  • date_range Jan 01, 2017
  • autorenew Implementation (Status)

Globally, infectious diseases such as pneumonia and sepsis are the leading cause of death and disability in children under five and are responsible for more than 3 million deaths a year. The situation is worsened by drug-resistant infections, as the limited number of treatments for children and babies are becoming less effective. More than 214,000 babies die each year from drug-resistant infections. Most of these deaths occur in low- and middle-countries.

more_horiz
Sectors:

  • Medical research

Participating Organisations

Global Antibiotic Research and Development Partnership Foundation Implementing
Bill & Melinda Gates Foundation Foundation Funding
UK - Department of Health and Social Care (DHSC) Government Funding
Japanese Ministry of Health, Labour & Welfare Government Funding
Leo Model Foundation Foundation Funding
Principality of Monaco Government Funding
The Netherlands Ministry of Health, Welfare and Sport Government Funding
South African Medical Research Council Other Public Sector Funding
German Federal Ministry of Education and Research Government Funding

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

10,425,361 USD
  • 8,882,251 EUR (Valued at Oct 06, 2020)
    date_range Jan 01, 2020 - Dec 31, 2020
access_time Updated on Nov 24, 2021 09:30:09